These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 27108536)

  • 41. Ectopic overexpression of CD133 in HNSCC makes it resistant to commonly used chemotherapeutics.
    Lee J; Park M; Ko Y; Kim B; Kim O; Hyun H; Kim D; Sohn H; Moon YL; Lim W
    Tumour Biol; 2017 Apr; 39(4):1010428317695534. PubMed ID: 28381190
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The FACT inhibitor CBL0137 Synergizes with Cisplatin in Small-Cell Lung Cancer by Increasing
    De S; Lindner DJ; Coleman CJ; Wildey G; Dowlati A; Stark GR
    Cancer Res; 2018 May; 78(9):2396-2406. PubMed ID: 29440145
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy.
    Liu J; Mao Z; Huang J; Xie S; Liu T; Mao Z
    Biochem Biophys Res Commun; 2014 Feb; 444(4):670-5. PubMed ID: 24502949
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced chemosensitivity by targeting Nanog in head and neck squamous cell carcinomas.
    Huang CE; Yu CC; Hu FW; Chou MY; Tsai LL
    Int J Mol Sci; 2014 Aug; 15(9):14935-48. PubMed ID: 25158233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High Notch1 expression affects chemosensitivity of head and neck squamous cell carcinoma to paclitaxel and cisplatin treatment.
    Zhang Z; Zhou Z; Zhang M; Gross N; Gong L; Zhang S; Lei D; Zeng Q; Luo X; Li G; Li X
    Biomed Pharmacother; 2019 Oct; 118():109306. PubMed ID: 31545250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of the combination of RAD001 and docetaxel on breast cancer stem cells.
    Zhang X; Zhang S; Liu Y; Liu J; Ma Y; Zhu Y; Zhang J
    Eur J Cancer; 2012 Jul; 48(10):1581-92. PubMed ID: 22420943
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
    So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antitumor effects of telomelysin in combination with paclitaxel or cisplatin on head and neck squamous cell carcinoma.
    Kondo N; Tsukuda M; Kimura M; Fujita K; Sakakibara A; Takahashi H; Ishiguro Y; Toth G; Matsuda H
    Oncol Rep; 2010 Feb; 23(2):355-63. PubMed ID: 20043095
    [TBL] [Abstract][Full Text] [Related]  

  • 49.
    Wang J; Fan J; Gao W; Wu Y; Zhao Q; Chen B; Ding Y; Wen S; Nan X; Wang B
    Stem Cells Dev; 2020 Jun; 29(12):774-785. PubMed ID: 32178572
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of integrin β1 as a biomarker of stemness in head and neck squamous cell carcinoma.
    Moon JH; Rho YS; Lee SH; Koo BS; Lee HJ; Do SI; Cho JH; Eun YG; Park MW; Shin HA; Lim YC
    Oral Oncol; 2019 Sep; 96():34-41. PubMed ID: 31422211
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate.
    Kallifatidis G; Labsch S; Rausch V; Mattern J; Gladkich J; Moldenhauer G; Büchler MW; Salnikov AV; Herr I
    Mol Ther; 2011 Jan; 19(1):188-95. PubMed ID: 20940707
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antitumor activity of cetuximab associated with the taxotere-cisplatin-fluorouracil (TPF) combination on an orthotopic head and neck cancer model.
    Bozec A; Sudaka A; Etienne-Grimaldi MC; Brunstein MC; Fischel JL; Milano G
    Oral Oncol; 2011 Oct; 47(10):940-5. PubMed ID: 21862388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting the c-Met/FZD8 signaling axis eliminates patient-derived cancer stem-like cells in head and neck squamous carcinomas.
    Sun S; Liu S; Duan SZ; Zhang L; Zhou H; Hu Y; Zhou X; Shi C; Zhou R; Zhang Z
    Cancer Res; 2014 Dec; 74(24):7546-59. PubMed ID: 25320014
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antitumor mechanisms of systemically administered epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck.
    Thomas SM; Ogagan MJ; Freilino ML; Strychor S; Walsh DR; Gooding WE; Grandis JR; Zamboni WC
    Mol Pharmacol; 2008 Mar; 73(3):627-38. PubMed ID: 18025070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
    Bi YL; Min M; Shen W; Liu Y
    Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cisplatin enhances the efficacy of 5-aminolevulinic acid mediated photodynamic therapy in human head and neck squamous cell carcinoma.
    Ahn JC; Biswas R; Mondal A; Lee YK; Chung PS
    Gen Physiol Biophys; 2014; 33(1):53-62. PubMed ID: 23846261
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Afatinib enhances the efficacy of conventional chemotherapeutic agents by eradicating cancer stem-like cells.
    Wang XK; He JH; Xu JH; Ye S; Wang F; Zhang H; Huang ZC; To KK; Fu LW
    Cancer Res; 2014 Aug; 74(16):4431-45. PubMed ID: 24972892
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological Disruption of the Notch1 Transcriptional Complex Inhibits Tumor Growth by Selectively Targeting Cancer Stem Cells.
    Alvarez-Trotta A; Guerrant W; Astudillo L; Lahiry M; Diluvio G; Shersher E; Kaneku H; Robbins DJ; Orton D; Capobianco AJ
    Cancer Res; 2021 Jun; 81(12):3347-3357. PubMed ID: 33820800
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-alpha in head and neck cancer cells in vitro and in vivo.
    Bruzzese F; Di Gennaro E; Avallone A; Pepe S; Arra C; Caraglia M; Tagliaferri P; Budillon A
    Clin Cancer Res; 2006 Jan; 12(2):617-25. PubMed ID: 16428508
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of cyclin D1 by shRNA is associated with enhanced sensitivity to conventional therapies for head and neck squamous cell carcinoma.
    Kothari V; Mulherkar R
    Anticancer Res; 2012 Jan; 32(1):121-8. PubMed ID: 22213296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.